Solventum Corporation

SOLV ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $92.0M $13.0M $63.0M $1.27B $90.0M $137.0M $31.0M $122.0M
Depreciation & Amortization $133.0M $135.0M $117.0M $121.0M $122.0M $129.0M $150.0M $133.0M
Depreciation $36.0M $38.0M $34.0M $37.0M $38.0M $42.0M $60.0M $37.0M
Amortization $90.0M $90.0M $76.0M $77.0M $78.0M $81.0M $88.0M $88.0M
Stock-Based Compensation $38.0M $51.0M $37.0M $41.0M $34.0M $49.0M $25.0M $27.0M
Net Cash from Operating Activities $227.0M $-189.0M $95.0M $76.0M $169.0M $29.0M $219.0M $169.0M
Investing Activities
Capital Expenditures $83.0M $84.0M $63.0M $97.0M $110.0M $109.0M $127.0M $93.0M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-87.0M $-77.0M $-745.0M $3.77B $-110.0M $-114.0M $-127.0M $-93.0M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $288.0M $67.0M — — $0 $0 — —
Net Cash from Financing Activities $-300.0M $-50.0M $-115.0M $-2.69B $-110.0M $-139.0M $-104.0M $-202.0M
Net Change in Cash $-157.0M $-318.0M $-764.0M $1.15B $-45.0M $-223.0M $-10.0M $-125.0M
Free Cash Flow $144.0M $-273.0M $32.0M $-21.0M $59.0M $-80.0M $92.0M $76.0M
← Newer Page 1 of 2 Older →